Chordia Therapeutics (TSE:190A) Days Payable : 0.00 (As of Aug. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Chordia Therapeutics Days Payable?

Chordia Therapeutics's average Accounts Payable for the six months ended in Aug. 2024 was 円0.00 Mil. Chordia Therapeutics's Cost of Goods Sold for the six months ended in Aug. 2024 was 円1,499.80 Mil. Hence, Chordia Therapeutics's Days Payable for the six months ended in Aug. 2024 was 0.00.

The historical rank and industry rank for Chordia Therapeutics's Days Payable or its related term are showing as below:

TSE:190A' s Days Payable Range Over the Past 10 Years
Min: 25.6 Med: 25.6 Max: 34.08
Current: 34.08

During the past 4 years, Chordia Therapeutics's highest Days Payable was 34.08. The lowest was 25.60. And the median was 25.60.

TSE:190A's Days Payable is ranked worse than
80.11% of 714 companies
in the Biotechnology industry
Industry Median: 127.14 vs TSE:190A: 34.08

Chordia Therapeutics's Days Payable stayed the same from Aug. 2022 (0.00) to Aug. 2024 (0.00).

Chordia Therapeutics Days Payable Historical Data

The historical data trend for Chordia Therapeutics's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chordia Therapeutics Days Payable Chart

Chordia Therapeutics Annual Data

Trend

Aug21

Aug22

Aug23

Aug24

Days Payable

25.60

Chordia Therapeutics Semi-Annual Data
	Aug21	Aug22	Aug23	Aug24
Days Payable	-	-	25.60	-

Competitive Comparison of Chordia Therapeutics's Days Payable

For the Biotechnology subindustry, Chordia Therapeutics's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Chordia Therapeutics's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Chordia Therapeutics's Days Payable distribution charts can be found below:

* The bar in red indicates where Chordia Therapeutics's Days Payable falls into.

Chordia Therapeutics Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Chordia Therapeutics's Days Payable for the fiscal year that ended in Aug. 2024 is calculated as

	Days Payable (A: Aug. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Aug. 2023 )	+	Accounts Payable (A: Aug. 2024 ))	/	count )	/	Cost of Goods Sold (A: Aug. 2024 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	1499.795	*	365
=	0					/	1499.795	*	365
=	0.00

Chordia Therapeutics's Days Payable for the quarter that ended in Aug. 2024 is calculated as:

	Days Payable (Q: Aug. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Aug. 2023 )	+	Accounts Payable (Q: Aug. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Aug. 2024 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	1499.795	*	365 / 2
=	0					/	1499.795	*	365 / 2
=	0.00

Chordia Therapeutics Days Payable Related Terms

Thank you for viewing the detailed overview of Chordia Therapeutics's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Chordia Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Chordia Therapeutics Inc (TSE:190A) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

2-26-1 Muraoka-Higashi, Kanagawa, Fujisawa, JPN, 251-0012

Website

https://www.chordiatherapeutics.com

Chordia Therapeutics Inc is a bio-venture company specializing in cancer research and development. Its mission is to deliver first-in-class cancer drugs to patients. It is a clinical-stage biotech company engaged in researching and developing novel therapies for cancers with high unmet medical needs.

Chordia Therapeutics Headlines

No Headlines